1. Home
  2. FRES vs MIRA Comparison

FRES vs MIRA Comparison

Compare FRES & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • MIRA
  • Stock Information
  • Founded
  • FRES 2010
  • MIRA 2020
  • Country
  • FRES United States
  • MIRA United States
  • Employees
  • FRES N/A
  • MIRA N/A
  • Industry
  • FRES Medical Specialities
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRES Health Care
  • MIRA Health Care
  • Exchange
  • FRES Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • FRES 70.9M
  • MIRA 9.4M
  • IPO Year
  • FRES 2020
  • MIRA 2023
  • Fundamental
  • Price
  • FRES $2.96
  • MIRA $0.59
  • Analyst Decision
  • FRES
  • MIRA
  • Analyst Count
  • FRES 0
  • MIRA 0
  • Target Price
  • FRES N/A
  • MIRA N/A
  • AVG Volume (30 Days)
  • FRES 10.1K
  • MIRA 38.4K
  • Earning Date
  • FRES 07-23-2024
  • MIRA 05-13-2024
  • Dividend Yield
  • FRES N/A
  • MIRA N/A
  • EPS Growth
  • FRES N/A
  • MIRA N/A
  • EPS
  • FRES N/A
  • MIRA N/A
  • Revenue
  • FRES $2,345,304.00
  • MIRA N/A
  • Revenue This Year
  • FRES N/A
  • MIRA N/A
  • Revenue Next Year
  • FRES N/A
  • MIRA N/A
  • P/E Ratio
  • FRES N/A
  • MIRA N/A
  • Revenue Growth
  • FRES N/A
  • MIRA N/A
  • 52 Week Low
  • FRES $2.50
  • MIRA $0.51
  • 52 Week High
  • FRES $41.80
  • MIRA $6.95
  • Technical
  • Relative Strength Index (RSI)
  • FRES 40.27
  • MIRA 37.81
  • Support Level
  • FRES $2.81
  • MIRA $0.51
  • Resistance Level
  • FRES $3.70
  • MIRA $0.62
  • Average True Range (ATR)
  • FRES 0.40
  • MIRA 0.05
  • MACD
  • FRES 0.00
  • MIRA -0.00
  • Stochastic Oscillator
  • FRES 35.94
  • MIRA 34.43

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: